Golden era reunion gala event
Sydney NSW 2000
AustraliaMaritime Ballroom, Hyatt Regency Sydney
Saturday 30 November from 6:30pm to 11:59pm
What began as a reunion of friends celebrating the golden era of ‘70s and ‘80s has evolved into a fundraising event.
This event is co-hosted by and supports two incredible organisations dedicated to funding research and support programs for patients with brain and other rare cancers: White Pearl Foundation and Cquence Foundation.
Our anticipated 500 - 600 attendees will include a diverse mix of some of Australia’s leading medical specialists, CEOs, leaders of business and the professions, community leaders, philanthropists, politicians and individuals who share a passion for supporting cancer research and patient care. This event will also provide a wonderful opportunity to connect with like-minded individuals and make a meaningful impact.
We look forward to welcoming you to an unforgettable evening!
The White Pearl Foundation was established to support the dedicated researchers of The Brain Cancer Group in their quest to find solutions for brain cancer patients.
The Brain Cancer Group is committed to improving patient outcomes across the spectrum – from patient care to working towards finding a cure for this devastating disease. They do this by taking a multi-disciplinary and collaborative approach to deliver meaningful programs for patients and their families.
They are also dedicated to funding cutting-edge research that will help us better understand brain cancer and develop new treatments. Their research efforts focus on the development and translation of new ways of treating brain tumours, while also seeking to better understand the genetic and environmental factors that contribute to the development of brain tumours.
All profits donated from White Pearl Foundation events to The Brain Cancer Group, go directly to brain cancer research.
Cquence Foundation's aim is to provide cancer patients, carers and their families a small ray of hope by:
helping subsidise molecular and genomic testing for rare and/or advanced cancer patients to see if there are any other treatment options.
generating awareness of testing options as well as other personalised integrative treatments for cancer patients.
advocating and lobbying government bodies to help fund genomic testing and subsequent PBS approved medications, and
helping rare and/or advanced cancer patients navigate the complexities of testing via arranging and funding "second opinions" with experts in the patient's cancer and driver mutations.
Cquence Foundation will donate 100% of profit received from this event to the Global Centre for Gynaecological Diseases at the University of Newcastle. This is a world-leading, translational research centre, focused on improving the gynaecological health of women.